Abstract
Pathogenic species of Cryptococcus kill approximately 200,000 people each year. The most important virulence mechanism of C. neoformans and C. gattii, the causative agents of human and animal cryptococcosis, is the ability to form a polysaccharide capsule. Acapsular mutants of C. neoformans are avirulent in mice models of infection, and extracellularly released capsular polysaccharides are deleterious to the immune system. The principal capsular component in the Cryptococcus genus is a complex mannan substituted with xylosyl and glucuronyl units, namely glucuronoxylomannan (GXM). The second most abundant component of the cryptococcal capsule is a galactan with multiple glucuronyl, xylosyl, and mannosyl substitutions, namely glucuronoxylomannogalactan (GXMGal). The literature about the structure and functions of these two polysaccharides is rich, and a number of comprehensive reviews on this topic are available. Here, we focus our discussion on the less explored glycan components associated with the cryptococcal capsule, including mannoproteins and chitin-derived molecules. These glycans were selected for discussion on the basis that i) they have been consistently detected not only in the cell wall but also within the cryptococcal capsular network and ii) they have functions that impact immunological and/or pathogenic mechanisms in the Cryptococcus genus. The reported functions of these molecules strongly indicate that the biological roles of the cryptococcal capsule go far beyond the well-known properties of GXM and GXMGal.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
1 Introduction: The Cryptococcal Capsule
Capsular structures are common surface components of bacterial pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis (Roberts 1996). C. neoformans and C. gattii are the only known eukaryotic pathogens that harbor capsules. The capsular network of Cryptococcus is the outermost layer surrounding the cell, concealing the cell wall and the plasma membrane (Fig. 1). The capsular barrier imposes additional difficulties for the design of new antifungal chemotherapies against cryptococcosis.
The capsule of Cryptococcus has been extensively studied, which is justified by its major role as a virulence factor (Bose et al. 2003; Zaragoza et al. 2009; Doering 2010; Wang et al. 2018). Structurally, the cryptococcal capsule is mainly composed by two polysaccharides. Glucuronoxylomannan (GXM) is the most abundant polysaccharide and consists of a chain of α1,3-linked mannose units with xylosyl and glucuronyl substitutions (Cherniak et al. 1998). GXM, which comprises around 90% of the total mass of the capsule, is also abundantly found in the extracellular milieu in the form of a heterodisperse, high molecular mass polysaccharide (1700–7000 kDa) (McFadden et al. 2006). The remainder 10% of the total mass of the capsule is mostly composed of glucuronoxylomannogalactan (GXMGal). GXMGal is formed by α1,6-linked galactose units with mannosyl, xylosyl, and glucuronyl substitutions (Heiss et al. 2009). The molecular mass of GXMGal corresponds to approximately 100 kDa (Zaragoza et al. 2009).
GXM and GXMGal are key players in physiological and immunopathogenic events in the Cryptococcus genus. Their biological roles, however, have been discussed in detail in several reviews (Doering 2010; Agustinho et al. 2018). Other components associated with the capsule have been overlooked. Mannoproteins (MPs) are considered by a number of authors as the third glycan component of the capsule (Zaragoza et al. 2009), but the connections of these glycoproteins with the major capsular structures have not been established. Additional glycans have also been observed within the capsular network of Cryptococcus, including chitin-derived structures. Although these glycans are not covalently linked to the major capsule components (Ramos et al. 2012), they have been consistently detected in different layers of the cryptococcal capsule (Rodrigues et al. 2008, 2015; Fonseca et al. 2009, 2013). Both MPs and chitin-derived structures participate in the interaction of Cryptococcus with the host (Voelz and May 2010; Fonseca et al. 2013; Teixeira et al. 2014; Rodrigues et al. 2015). Here, we will discuss the roles of these two classes of glycans as components of the cryptococcal capsule.
2 Chitin and Capsular Architecture of Cryptococcus
Chitin metabolism in fungi involves a number of key structures, including its de-acetylated form (chitosan), the products of chitin hydrolysis (chitooligomers), and the enzymes involved in the balance between chitin synthesis (chitin synthases) and hydrolysis (chitinases). Each of them participates in the capsular architecture of Cryptococcus, as detailed in the following topics.
2.1 Chitin and Chitin Synthases
Chitin is a structural component of the fungal cell wall, accounting for approximately 2% of the wall mass (Camacho et al. 2017; Agustinho et al. 2018). This ancestral polysaccharide is a linear homopolymer composed of ß-1,4-linked units of N-acetylglucosamine (GlcNAc). Microfibrils of stacked chitin chains are stabilized by hydrogen bonds, assuring insolubility and mechanical strength (Doering 2010; Gonzalez et al. 2010). However, the view that chitin is an exclusive structural component providing protection from the internal hydrostatic pressure exerted on the wall by the cytoplasm and/or by environmental stresses (Gow et al. 2017) is now considered minimalist. In Cryptococcus, chitin is in fact a scaffold structure of the cell wall (Agustinho et al. 2018), but the polysaccharide also participates in capsular architecture (Rodrigues et al. 2008, 2018; Fonseca et al. 2009; Ramos et al. 2012) and assembly of melanin into the cell wall (Banks et al. 2005; Baker et al. 2007; Camacho et al. 2017). In addition, chitin has been demonstrated to modulate the host’s immune response (Da Silva et al. 2008, 2009; Wagener et al. 2014; Wiesner et al. 2015; Ost et al. 2017). Therefore, this molecule is crucial for both cryptococcal physiology and pathogenesis.
Chitin is polymerized by membrane-associated chitin synthases, which use cytosolic UDP-N-acetyl-d-glucosamine as a sugar donor (Doering 2010). Eight putative cryptococcal chitin synthase genes (CHS1–CHS8) and three regulator proteins (Csr1–Csr3) have been identified in C. neoformans (Banks et al. 2005). It is therefore assumed that chitin synthesis is highly redundant in this fungus, which is likely related to its low susceptibility to nikkomycin, an inhibitor of chitin synthesis (Rinaldi 1999; Banks et al. 2005). Importantly, none of the chitin synthase or chitin synthase regulator genes are essential for cryptococcal viability (Banks et al. 2005; Rodrigues et al. 2018). Recent evidence, however, indicated that chitin synthesis is required for the correct capsular architecture of C. neoformans. Deletion of seven out of the eight CHS genes resulted in aberrant capsular morphologies and altered polysaccharide dimensions (Rodrigues et al. 2018). Five of the eight CHS genes were required for the serological reactivity of capsular GXM, while the functionality of all eight genes was required for full polysaccharide secretion, in comparison with parental cells regularly expressing the CHS genes. (Rodrigues et al. 2018). These results clearly demonstrate that chitin synthesis and capsular formation are connected in C. neoformans. Remarkably, deletion of CHS genes also affected extracellular vesicle formation and chitinase activity (Rodrigues et al. 2018), which are events that also participate in capsular architecture (Rodrigues et al. 2007; Fonseca et al. 2009).
2.2 Chitooligomers
Chitooligomers or chitooligosaccharides are chitin-derived structures composed of 3–20 residues of β1,4-linked N-acetylglucosamine, produced enzymatically by chitinase-mediated chitin hydrolysis (Fonseca et al. 2013). These structures efficiently react with the wheat germ lectin (WGA) (Foster et al. 2004).
The demonstration that chitin-related structures are part of the capsular network in C. neoformans was generated by a combination of microscopic, biochemical, and pharmacological approaches. The first suggestion that chitin-derived structures and capsular components were associated was originated from the microscopic detection of chitin oligomers within the capsular network of both C. neoformans and C. gattii (Rodrigues et al. 2008). In Cryptococcus, WGA recognized chitooligomers with high affinity (Rodrigues et al. 2008; Fonseca et al. 2009, 2013). The chitooligosaccharides were detected at the cell wall but, unexpectedly, they were also found as projections emerging from the cell wall into the cryptococcal capsule, apparently connecting these two layers of the fungal surface. Chitooligomers formed round and hook-like structures detected within the capsule, as well as ringlike structures around the bud neck (Rodrigues et al. 2008).
The apparent association between capsular components and chitooligosaccharides was confirmed through different approaches. Chromatographic analysis revealed that hybrid glycans containing GXM and chitooligomers were found in their soluble form in culture supernatants, suggesting that formation of the complexes is a common event in the cryptococcal physiology (Fonseca et al. 2009). In the presence of the oligomers, capsular fibers increased in size, reinforcing the suggestion of intermolecular interactions between GXM and chitin-derived structures (Fonseca et al. 2009). Pharmacological inhibition of the synthesis of glucosamine 6-phosphate, a precursor of UDP-GlcNAc synthesis, resulted in decreased chitin detection and faulty capsules with clearly reduced dimensions (Fonseca et al. 2009). Structural analysis of the complexes formed by chitin and GXM revealed the requirement of chitin’s N-acetyl groups for an efficient, non-covalent interglycan interaction (Ramos et al. 2012). The association of chitin-related structures and capsular components had a dramatic impact on the physiology of C. neoformans. Blocking of chitooligomers with WGA resulted in reduced concentrations of extracellular GXM and decreased capsular dimensions (Fonseca et al. 2013). In addition, the transcription levels of genes involved in the synthesis, cellular traffic, and signaling pathways controlling capsule formation were also reduced (Fonseca et al. 2013).
The functional impact of the GXM–chitin association was not limited to the cryptococcal physiology. The interaction between chitooligomers and GXM resulted in stable, hybrid glycans with immunological functions that differed from each molecule alone (Ramos et al. 2012). Hybrid molecules were efficient inducers of lung tumor necrosis factor alpha (TNF-α), interleukin 10 (IL-10) and IL-17 in mice, suggesting that the association of GXM with chitooligomers produced molecules with unique immunological functions (Ramos et al. 2012). This observation is also in agreement with the notion that molecular interactions within the capsule can generate a number of complex structures with still unknown immunological functions.
Chitin-derived molecules were detected in outer layers of the capsule of C. neoformans and C. gattii (Rodrigues et al. 2008), suggesting that they could participate in the interaction of each pathogen with host cells. In fact, chitin-derived surface components affected the interaction of C. neoformans with the host at multiple levels (Fonseca et al. 2013). Toll-like receptor (TLR) 2, Dectin-1, and mannose receptor have been associated with immune responses to chitin resulting in the production of TNF-α and IL-10 (Da Silva et al. 2008, 2009; Bueter et al. 2013). Both murine and human macrophages produced IL-10 in response to cryptococcal chitin, in processes that likely required activation of NOD2 and TLR-9 (Heung 2017). WGA-treated C. neoformans were attenuated in virulence and had a poor capacity of dissemination to the central nervous system (Fonseca et al. 2013). Treatment of C. neoformans with WGA also resulted in reduced levels of interaction with host macrophages through mechanisms that required TLR-2 (Fonseca et al. 2013), suggesting that chitooligomer recognition is part of a Trojan horse mechanism of dissemination to the brain (Casadevall 2010). Accordingly, brain infection with C. gattii was further associated with increased chitooligomer distribution at the surface of fungal cells in mice (Rodrigues et al. 2015). Moreover, chitin stimulated Th2 responses during C. neoformans infection of mice through mechanisms that required polysaccharide cleavage by chitotriosidase, a mammalian chitinase (Wiesner et al. 2015). Increased chitooligomer distribution also correlated with peaks of chitinase activity in the lungs of infected mice (Rodrigues et al. 2015), suggesting that chitin hydrolysis, chitooligomer formation, capsule assembly, and pathogenesis are linked in Cryptococcus, as discussed below.
2.3 Chitinases
Chitooligomers are produced through chitin hydrolysis by both fungal and host chitinases (Goldman and Vicencio 2012; Ramos et al. 2012). Fungal chitinases have an important role in cell wall remodeling during growth, morphogenesis, and cell division (Adams 2004). In experimental models of cryptococcosis, expression of chitinases varied according to the infected anatomic site (Fonseca et al. 2009). For instance, chitinase activity was induced in mice lungs infected with C. neoformans, but not in the brain (Overdijk et al. 1999; Vicencio et al. 2008). Intratracheal infection with C. neoformans also resulted in increased detection of chitinase activity in bronchoalveolar lavage fluids and lung homogenates of rats (Vicencio et al. 2008). Importantly, surface detection of chitooligomers in both C. neoformans and C. gattii was increased in lung tissues manifesting higher activity of chitinase (Fonseca et al. 2009, 2013; Rodrigues et al. 2015). Chitinase activity was also responsible for producing soluble, extracellular oligomeric structures of chitin that formed hybrid glycans with GXM during regular growth and macrophage infection, as concluded from the reduced formation of the hybrid structures in the presence of a chitinase inhibitor (Ramos et al. 2012; Rodrigues and Nimrichter 2012). Chitinase activity in C. neoformans under stress conditions (Rodrigues et al. 2018), which are known to induce capsule formation (Zaragoza and Casadevall 2004), was enhanced in both intracellular and extracellular fractions from C. neoformans (Rodrigues et al. 2018), suggesting that enzyme activity and chitooligomer formation are stimulated during capsule enlargement.
2.4 Chitosan
Differently from other fungi, chitin in C. neoformans is mostly de-acetylated by chitin deacetylases to form chitosan (Banks et al. 2005). The CDA1, CDA2, and CDA3 genes are required for chitin deacetylation, but the presence of only one of these three chitin deacetylases is sufficient for chitosan production, suggesting metabolic redundancy (Baker et al. 2007). Cryptococcal chitosan levels may exceed the cellular amount of chitin by up to tenfold (Banks et al. 2005). The de-acetylated polysaccharide confers flexibility to the cell wall (Wang et al. 2018), which is essential for the molecular traffic across this cellular layer (Rodrigues and Casadevall 2018). Chitosan also contributes to the maintenance of cell wall integrity and bud separation (Banks et al. 2005; Wang et al. 2018). Importantly, chitosan is essential for melanin deposition on the cell wall of C. neoformans (Banks et al. 2005; Baker et al. 2007, 2011). Melanin is a cell wall pigment implicated in fungal pathogenicity (Nosanchuk and Casadevall 2006), resistance to environmental stress (Wang and Casadevall 1994; Nosanchuk and Casadevall 2006), and decreased susceptibility to antifungal drugs (Wang and Casadevall 1994; Martinez and Casadevall 2006).
Lack of chitosan critically impacts C. neoformans virulence (Baker et al. 2011). Fungal cells lacking chitosan synthesis manifest unstable cell walls, slow growth at 37 ℃, and increased vulnerability to host defense mechanisms, with consequent inability to kill mice (Baker et al. 2011). Furthermore, chitosan-deficient cda1cda2cda3∆ mutants were not pathogenic and induced robust inflammatory, protective responses (Baker et al. 2011; Upadhya et al. 2016). In this context, heat-killed cda1cda2cda3∆ cells have been suggested as prototypes for vaccine development in the Cryptococcus model (Upadhya et al. 2016).
3 Mannoproteins
The cryptococcal surface contains highly mannosylated glycoproteins, namely mannoproteins (MPs). The main structural features of MPs include a signal sequence for post-Golgi secretion, a site for attachment of glycosylphosphatidylinositol (GPI) anchors, and a serine-/threonine-rich region, which bears extensive O-mannosylation (Levitz and Specht 2006). MPs are in close association with the cryptococcal capsule, and early estimates suggest they account for less than 1% of the capsular mass (Bose et al. 2003; Zaragoza et al. 2009). MPs are predominantly located in the inner region of the capsule, close to the cell wall (Jesus et al. 2010), but the fact that they contain secretory tags might suggest that they are transitory capsular components being transported to the extracellular space (Biondo et al. 2006; Eigenheer et al. 2007; Jesus et al. 2010; Agustinho et al. 2018).
Cryptococcal MPs are highly immunogenic and immunostimulatory (Chaka et al. 1997; Levitz and Specht 2006). MPs stimulate a massive production of IL-12 by human monocytes (Pitzurra et al. 2000). Binding of MPs to the mannose receptor of dendritic cells led to activation of T cells and protective immunity against C. neoformans (Specht et al. 2007; Dan et al. 2008a, b). Inhibition of mannose receptors or MP deglycosylation strongly prevented activation of T cell responses, indicating the essential contribution of mannosylation to immunogenicity (Levitz and Specht 2006). On the basis of these observations, MPs have been proposed as potential vaccine candidates against cryptococcosis (reviewed by Van Dyke and Wormley (2018)).
Bioinformatic analysis using the proteomes of C. neoformans and C. gattii revealed the putative occurrence of 43 and 36 predicted MPs, respectively (Reuwsaat et al. 2018). However, most of them remain to be characterized at the functional and structural levels. Levitz and colleagues explored the functions of C. neoformans MP98 in stimulating T cell responses using murine hybridomas (Levitz et al. 2001). MP98 is encoded by chitin deacetylase 2 gene (CDA2), which is responsible for converting chitin to chitosan. This protein, which is GPI-anchored to the plasma membrane, is associated with the cell wall. However, MP98 association with the cell wall is independent of both the GPI anchor and β-1,6-glucan (Gilbert et al. 2012). Similarly, MP88 is involved in T cell activation, sharing several structural features with MP98, which include a serine-/threonine-rich C-terminal region and a GPI anchor motif (Huang et al. 2002). Nevertheless, a supposed function for MP88 based on sequence similarity analysis has not been assigned (Levitz and Specht 2006). Other cryptococcal MPs that have been studied at the functional level include MP84 and MP115, which are recognized by serum antibodies from AIDS patients with cryptococcosis (Biondo et al. 2005). MP84 and MP115 have homology to polysaccharide deacetylase and carboxylesterase proteins, respectively. Furthermore, MP84 mediates the adhesion of C. neoformans to lung epithelial cells (Teixeira et al. 2014). Lastly, the C. neoformans CIG1 gene encodes a secreted mannoprotein (Cig1) involved in a heme uptake system. Cig1 influences C. neoformans virulence in a mouse model of cryptococcosis but only in a strain that also lacked the high-affinity iron uptake system (Cadieux et al. 2013).
The roles of cryptococcal MPs in capsule structure and assembly have not been fully addressed. Recently, Reuwsaat et al. characterized a C. gattii putative MP, namely Kpr1, and suggested that it participates in capsular structure and GXM release (Reuwsaat et al. 2018). The kpr1 null mutant cells were more sensitive to congo red, a classical cell wall stressor that disrupts beta-glucan synthesis. Gene knockout affected cell-associated cryptococcal polysaccharide thickness and phagocytosis by J774.A1 macrophages. Furthermore, recombinant Krp1 was selectively recognized by serum from patients with cryptococcosis (Reuwsaat et al. 2018). The in vivo pathogenic potential of C. gattii, however, was not affected by KPR1 deletion. These data suggest a role of Kpr1 in capsule assembly in C. gattii.
The studies showing key biological functions of MPs contrast with the fact that only a minor fraction of cryptococcal MPs has been functionally characterized. In addition, the glycan moieties of cryptococcal glycoproteins have never been structurally determined. This scenario stimulates studies on the roles of MPs in the pathogenesis of C. neoformans and C. gattii.
4 Conclusions
It is now clear that the capsule of Cryptococcus is much more complex in composition and functions than initially thought. GXM and GXMGal are unquestionably major capsular components with fundamental biological functions, but the capsular network assuredly includes less abundant and even transitory components that might impact biological functions and pathogenic potential. The roles of these overlooked capsular components remain largely unexplored. Finally, intermolecular interactions within the capsular network are expected, as well as the formation of multimolecular structures with completely unknown roles in physiopathogenesis. Although the progress in the understanding on how the capsular components of Cryptococcus impact physiology and pathogenesis is incontestable, it seems clear that there is still much to learn about the functional multiplicity of the cryptococcal capsule.
References
Adams D (2004) Fungal cell wall chitinases and glucanases. Microbiol (United Kingdom) 150:2029–2035. https://doi.org/10.1099/mic.0.26980-0
Agustinho DP, Miller LC, Li LX, Doering TL (2018) Peeling the onion: the outer layers of Cryptococcus neoformans. Mem Inst Oswaldo Cruz 113:e180040. https://doi.org/10.1590/0074-02760180040
Albuquerque PC, Fonseca FL, Dutra FF et al (2014) Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. Future Microbiol 9:147–161. https://doi.org/10.2217/fmb.13.163
Baker LG, Specht C a, Donlin MJ, Lodge JK (2007) Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell 6:855–867. https://doi.org/10.1128/ec.00399-06
Baker LG, Specht C a, Lodge JK (2011) Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans. Eukaryot Cell 10:1264–1268. https://doi.org/10.1128/ec.05138-11
Banks IR, Specht C a, Donlin MJ et al (2005) A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Eukaryot Cell 4:1902–1912. https://doi.org/10.1128/ec.4.11.1902
Biondo C, Mancuso G, Midiri A et al (2006) Identification of major proteins secreted by Cryptococcus neoformans. FEMS Yeast Res 6:645–651. https://doi.org/10.1111/j.1567-1364.2006.00043.x
Biondo C, Messina L, Bombaci M et al (2005) Characterization of two novel cryptococcal mannoproteins recognized by immune sera. Infect Immun 73:7348–7355. https://doi.org/10.1128/IAI.73.11.7348-7355.2005
Bose I, Reese AJ, Ory JJ et al (2003) A yeast under cover: the capsule of Cryptococcus neoformans. Eukaryot Cell 2:655–663
Bueter CL, Specht CA, Levitz SM (2013) Innate sensing of chitin and chitosan. PLoS Pathog 9:1–3. https://doi.org/10.1371/journal.ppat.1003080
Caballero Van Dyke MC, Wormley FL Jr (2018) A call to arms: quest for a cryptococcal vaccine. Trends Microbiol 26:436–446. https://doi.org/10.1016/j.tim.2017.10.002
Cadieux B, Lian T, Hu G et al (2013) The mannoprotein Cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans. J Infect Dis 207:1339–1347. https://doi.org/10.1093/infdis/jit029
Camacho E, Chrissian C, Cordero RJB et al (2017) N-acetylglucosamine affects Cryptococcus neoformans cell-wall composition and melanin architecture. Microbiol (United Kingdom) 163:1540–1556. https://doi.org/10.1099/mic.0.000552
Casadevall A (2010) Cryptococci at the brain gate: break and enter or use a Trojan horse? J Clin Invest 120:1389–1392. https://doi.org/10.1172/JCI42949
Chaka W, Verheul AF, Vaishnav VV et al (1997) Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol 159:2979–2985
Cherniak R, Valafar H, Morris LC, Valafar F (1998) Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5:146–159
Da Silva CA, Chalouni C, Williams A et al (2009) Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J Immunol 182:3573–3582. https://doi.org/10.4049/jimmunol.0802113
Da Silva CA, Hartl D, Liu W et al (2008) TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J Immunol 181:4279–4286. https://doi.org/10.4049/jimmunol.181.6.4279
Dan JM, Kelly RM, Lee CK, Levitz SM (2008a) Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun 76:2362–2367. https://doi.org/10.1128/IAI.00095-08
Dan JM, Wang JP, Lee CK, Levitz SM (2008b) Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. PLoS ONE 3:e2046. https://doi.org/10.1371/journal.pone.0002046
Doering TL (2010) How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbio 223–247. https://doi.org/10.1146/annurev.micro.62.081307.162753.how
Eigenheer RA, Jin Lee Y, Blumwald E et al (2007) Extracellular glycosylphosphatidylinositol-anchored mannoproteins and proteases of Cryptococcus neoformans. FEMS Yeast Res 7:499–510. https://doi.org/10.1111/j.1567-1364.2006.00198.x
Fonseca FL, Guimarães AJ, Kmetzsch L et al (2013) Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis. Fungal Genet Biol 60:64–73. https://doi.org/10.1016/j.fgb.2013.04.005
Fonseca FL, Nimrichter L, Cordero RJB et al (2009) Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans∇. Eukaryot Cell 8:1543–1553. https://doi.org/10.1128/EC.00142-09
Fonseca FL, Nohara LL, Cordero RJB et al (2010) Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter. Infect Immun 78:3861–3870. https://doi.org/10.1128/IAI.00111-10
Foster AJ, Bird RA, Kelly SL, Nishimura K, Poyner D, Taylor SSS (2004) FITC-lectin avidity of Cryptococcus neoformans cell wall and capsular components. Mycology 96:1–8
Gilbert NM, Baker LG, Specht C a, Lodge JK (2012) A Glycosylphosphatidylinositol anchor is required for membrane localization but dispensable for cell wall association of chitin deacetylase 2 in Cryptococcus neoformans. MBio 3:e00007-12–e00007-12. https://doi.org/10.1128/mbio.00007-12
Goldman DL, Vicencio AG (2012) The chitin connection. MBio
Gonzalez M, de Groot PWJ, Klis FM, Lipke PN (2010) Glycoconjugate structure and function in fungal cell walls. Elsevier Inc, First edit
Gow N a R, Latge J, Munro C a (2017) The fungal cell wall : structure, biosynthesis, and function. Microbiol Spectr 5:1–25. https://doi.org/10.1128/microbiolspec.funk-0035-2016.correspondence
Heiss C, Stacey Klutts J, Wang Z et al (2009) The structure of Cryptococcus neoformans galactoxylomannan contains β-d-glucuronic acid. Carbohydr Res 344:915–920. https://doi.org/10.1016/j.carres.2009.03.003
Heung L (2017) Innate immune responses to cryptococcus. J Fungi 3:35. https://doi.org/10.3390/jof3030035
Huang C, Nong SH, Mansour MK et al (2002) Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses. Infect Immun 70:5485–5493
Jesus MD, Nicola AM, Chow SK et al (2010) Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence 1:500–508
Levitz SM, Nong S, Mansour MK et al (2001) Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc Natl Acad Sci U S A 98:10422–10427. https://doi.org/10.1073/pnas.181331398
Levitz SM, Specht CA (2006) The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res 6:513–524. https://doi.org/10.1111/j.1567-1364.2006.00071.x
Martinez LR, Casadevall A (2006) Susceptibility of Cryptococcus neoformans Biofilms to antifungal agents in vitro susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 50:1021–1033. https://doi.org/10.1128/AAC.50.3.1021
McFadden D, Zaragoza O, Casadevall A (2006) The capsular dynamics of Cryptococcus neoformans. Trends Microbiol 14:497–505. https://doi.org/10.1016/j.tim.2006.09.003
Nosanchuk JD, Casadevall A (2006) Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother 50:3519–3528. https://doi.org/10.1128/AAC.00545-06
Ost KS, Esher SK, Wager ML et al (2017) Rim pathway-mediated alterations in the fungal cell wall influence immune recognition and inflammation. MBio 8
Overdijk Bernard, Steijn Van, Gé J, Odds FC (1999) Distribution of chitinase in guinea pig tissues and increases in levels of this enzyme after systemic infection with Aspergillus fumigatus. Microbiol (United Kingdom) 145:259–269. https://doi.org/10.1099/13500872-145-1-259
Pitzurra L, Cherniak R, Giammarioli M et al (2000) Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infect Immun 68:558–563
Ramos CL, Fonseca FL, Rodrigues J et al (2012) Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Eukaryot Cell 11:1086–1094. https://doi.org/10.1128/EC.00001-12
Reuwsaat JCV, Motta H, Garcia AWA et al (2018) A predicted mannoprotein participates in Cryptococcus gattii capsular structure. mSphere 3. https://doi.org/10.1128/msphere.00023-18
Rinaldi MG (1999) In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother 43:1401–1405
Roberts IS (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 50:285–315. https://doi.org/10.1146/annurev.micro.50.1.285
Rodrigues J, Fonseca FL, Schneider RO et al (2015) Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates. Sci Rep 5:1–13. https://doi.org/10.1038/srep11717
Rodrigues J, Ramos CL, Frases S et al (2018) Lack of chitin synthase genes impacts capsular architecture and cellular physiology in Cryptococcus neoformans. Cell Surf. https://doi.org/10.1016/j.tcsw.2018.05.002
Rodrigues ML, Alvarez M, Fonseca FL, Casadevall A (2008) Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell 7:602–609. https://doi.org/10.1128/EC.00307-07
Rodrigues ML, Casadevall A (2018) A two-way road: novel roles for fungal extracellular vesicles. Mol Microbiol. https://doi.org/10.1111/mmi.14095
Rodrigues ML, Nimrichter L (2012) In good company: association between fungal glycans generates molecular complexes with unique functions. Front Microbiol 3:1–5. https://doi.org/10.3389/fmicb.2012.00249
Rodrigues ML, Nimrichter L, Oliveira DL et al (2007) Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 6:48–59. https://doi.org/10.1128/EC.00318-06
Specht CA, Nong S, Dan JM et al (2007) Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. J Infect Dis 196:796–800. https://doi.org/10.1086/520536
Teixeira PA, Penha LL, Mendonca-Previato L, Previato JO (2014) Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells. Front Cell Infect Microbiol 4:106. https://doi.org/10.3389/fcimb.2014.00106
Upadhya R, Lam WC, Maybruck B et al (2016) Induction of protective immunity to cryptococcal infection in mice by a heat-killed, chitosan-deficient strain of Cryptococcus neoformans. MBio 7:1–14. https://doi.org/10.1128/mBio.00547-16
Vicencio AG, Narain S, Du Z et al (2008) Pulmonary cryptococcosis induces chitinase in the rat. Respir Res 9:1–6. https://doi.org/10.1186/1465-9921-9-40
Voelz K, May RC (2010) Cryptococcal interactions with the host immune system. Eukaryot Cell 9:835–846. https://doi.org/10.1128/EC.00039-10
Wagener J, Malireddi RKS, Lenardon MD et al (2014) Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog 10. https://doi.org/10.1371/journal.ppat.1004050
Wang Y, Casadevall A (1994) Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun 62:3004–3007. doi: 0019-9567/94/$04.OO+O
Wang Z a, Li LX, Doering TL (2018) Unraveling synthesis of the cryptococcal cell wall and capsule. Glycobiology 1–12. https://doi.org/10.1093/glycob/cwy030
Wiesner DL, Specht CA, Lee CK et al (2015) Chitin recognition via chitotriosidase promotes pathologic Type-2 helper T cell responses to cryptococcal infection. PLoS Pathog 11:1–28. https://doi.org/10.1371/journal.ppat.1004701
Zaragoza O, Casadevall A (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6:10–15. https://doi.org/10.1251/bpo68
Zaragoza O, Rodrigues ML, De Jesus M et al (2009) The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol 68:133–216. doi: S0065-2164(09)01204-0 [pii]10.1016/S0065-2164(09)01204-0
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fonseca, F.L., Reis, F.C.G., Sena, B.A.G., Jozefowicz, L.J., Kmetzsch, L., Rodrigues, M.L. (2018). The Overlooked Glycan Components of the Cryptococcus Capsule. In: Rodrigues, M. (eds) Fungal Physiology and Immunopathogenesis . Current Topics in Microbiology and Immunology, vol 422. Springer, Cham. https://doi.org/10.1007/82_2018_140
Download citation
DOI: https://doi.org/10.1007/82_2018_140
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30236-8
Online ISBN: 978-3-030-30237-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)